Cargando…
Management of patients with non-Hodgkin’s lymphoma: focus on adoptive T-cell therapy
Non-Hodgkin’s lymphoma (NHL) represents a heterogeneous group of malignancies with high diversity in terms of biology, clinical responses, and prognosis. Standard therapy regimens produce a 5-year relative survival rate of only 69%, with the critical need to increase the treatment-success rate of th...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918257/ https://www.ncbi.nlm.nih.gov/pubmed/27471712 http://dx.doi.org/10.2147/ITT.S31389 |